A Gene Marker Panel Covering the WNT and the Ras-Raf-Mek-Mapk Signalling Pathways Allows to Detect Gene Mutations in 80% of Early (UICC I) Colon Cancer Stages in Humans

Cancer Epidemiology - Netherlands
doi 10.1016/j.canep.2009.05.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

An Update on the Biology of RAS/RAF Mutations in Colorectal Cancer

Current Colorectal Cancer Reports
HepatologyOncologyGastroenterology
2011English

Molecular Signaling in Multiple Myeloma: Association of RAS/RAF Mutations and MEK/ERK Pathway Activation

Oncogenesis
Cancer ResearchMolecular Biology
2017English

Targeting the Ras/Raf/Mek/Erk Pathway in Hepatocellular Carcinoma (Review)

Oncology Letters
Cancer ResearchOncology
2017English

Conferring Specificity on the Ubiquitous Raf/Mek Signalling Pathway

British Journal of Cancer
Cancer ResearchOncology
2004English

Mutations in the Ras-Raf Axis Underlie the Prognostic Value of CD133 in Colorectal Cancer

Clinical Cancer Research
Cancer ResearchOncology
2012English

Inter-Cellular Adhesion Disruption and the RAS/RAF and Beta-Catenin Signalling in Lung Cancer Progression

Cancer Cell International
Cancer ResearchOncologyGenetics
2008English

MEK1 Mutations Confer Resistance to MEK and B-Raf Inhibition

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

Germline Mutations in the TGF-beta and WNT Signalling Pathways Are a Rare Cause of the "Multiple" Adenoma Phenotype

Journal of Medical Genetics
Genetics
2003English

Effects of RAF Inhibitors on PI3K/AKT Signalling Depend on Mutational Status of the RAS/RAF Signalling Axis

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy